2016
DOI: 10.1002/anie.201605990
|View full text |Cite
|
Sign up to set email alerts
|

Whole‐Cell‐Catalyzed Multiple Regio‐ and Stereoselective Functionalizations in Cascade Reactions Enabled by Directed Evolution

Abstract: Biocatalytic cascade reactions using isolated stereoselective enzymes or whole cells in one-pot processes lead to value-added chiral products in a single workup. The concept has been restricted mainly to starting materials and intermediate products that are accepted by the respective wild-type enzymes. In the present study, we exploited directed evolution as a means to create E. coli whole cells for regio- and stereoselective cascade sequences that are not possible using man-made catalysts. The approach is ill… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
64
0
5

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 82 publications
(70 citation statements)
references
References 38 publications
1
64
0
5
Order By: Relevance
“…have recently reported the production of 4‐hydroxy‐α‐isophorone (HIP, 6 , Scheme ) from α‐IP to a pilot scale using the well‐known P450‐BM3 from Bacillus megaterium (CYP102A1), paving the way for a sustainable P450‐based KIP production. On the other hand, several reports deal with the application of P450s to catalyse the initial C−H activation in one‐pot multi‐enzymatic transformations: examples are the oxyfunctionalisation of linear hydrocarbons (both in vitro and in vivo), the production of cycloalkanones or lactones from the corresponding cycloalkanes, the synthesis the grapefruit flavour (+)‐nootkatone, the conversion of cyclohexane to cyclohexanediols, and the stereoselective benzylic amination of ethylbenzene derivatives . Therefore, considering these biocatalytic strategies, we designed a cascade system to access KIP from α‐IP through a double allylic oxidation (Scheme ), employing a P450 in the first step to afford HIP, followed by further oxidation by an alcohol dehydrogenase (ADH).…”
Section: Introductionmentioning
confidence: 99%
“…have recently reported the production of 4‐hydroxy‐α‐isophorone (HIP, 6 , Scheme ) from α‐IP to a pilot scale using the well‐known P450‐BM3 from Bacillus megaterium (CYP102A1), paving the way for a sustainable P450‐based KIP production. On the other hand, several reports deal with the application of P450s to catalyse the initial C−H activation in one‐pot multi‐enzymatic transformations: examples are the oxyfunctionalisation of linear hydrocarbons (both in vitro and in vivo), the production of cycloalkanones or lactones from the corresponding cycloalkanes, the synthesis the grapefruit flavour (+)‐nootkatone, the conversion of cyclohexane to cyclohexanediols, and the stereoselective benzylic amination of ethylbenzene derivatives . Therefore, considering these biocatalytic strategies, we designed a cascade system to access KIP from α‐IP through a double allylic oxidation (Scheme ), employing a P450 in the first step to afford HIP, followed by further oxidation by an alcohol dehydrogenase (ADH).…”
Section: Introductionmentioning
confidence: 99%
“… Cascade biotransformations of alkanes with E. coli cells. a) Oxidation of cyclooctane to cyclooctenone; b) conversion of octane to octylamine; c) conversion of cyclohexane to ( R , R )‐, ( S , S )‐, or meso ‐cyclohexane‐1,2‐diol …”
Section: Recent Development Of Whole‐cell Cascade Biotransformationsmentioning
confidence: 99%
“…Recently, Reetz and co‐workers presented another excellent example of artificial whole‐cell cascade (Scheme c) . Directed evolution of P450‐BM3 gave two unique mutants, P450A82F and P450A82F/A328F, catalyzing the 3‐step oxidation of cyclohexane to ( R )‐ and ( S )‐2‐hydroxycyclohexanone, respectively.…”
Section: Recent Development Of Whole‐cell Cascade Biotransformationsmentioning
confidence: 99%
“…However, there are very few known processes that integrate bio-orthogonal reactions catalyzed by transition-metal catalysts into multi-step biocatalytic systems in cells for complex transformations. The progress of developing biocompatible transition-metal complexes that function in cells, together with strategies of engineering enzymatic multi-step catalysis in vivo [112,113], will open new windows for creating new cell factories for chemical production.…”
Section: Future Prospects and Conclusionmentioning
confidence: 99%